# reload+after+2024-01-21 06:46:53.638499
address1§2051 Ringwood Avenue
city§San Jose
state§CA
zip§95131
country§United States
phone§408 457 3700
website§https://www.ranitherapeutics.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including large molecules, such as peptides, proteins, and antibodies. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The company was incorporated in 2012 and is headquartered in San Jose, California.
fullTimeEmployees§163
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Mir A. Imran', 'age': 67, 'title': 'Executive Chairman', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 80000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Talat  Imran', 'age': 41, 'title': 'CEO & Director', 'yearBorn': 1982, 'fiscalYear': 2022, 'totalPay': 827000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Svai S. Sanford', 'age': 53, 'title': 'Chief Financial Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 661600, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mir  Hashim', 'age': 63, 'title': 'Chief Scientific Officer', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 661600, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eric  Groen', 'age': 52, 'title': 'General Counsel', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Bella  Vazquez', 'title': 'Vice President of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kate  McKinley M.B.A.', 'title': 'Chief Business Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.942
currency§USD
dateShortInterest§1702598400
forwardEps§-1.0
pegRatio§0.24
exchange§NGM
quoteType§EQUITY
shortName§Rani Therapeutics Holdings, Inc
longName§Rani Therapeutics Holdings, Inc.
firstTradeDateEpochUtc§1627651800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§5ed5bf18-2fc9-357f-8d44-03f1c0fe19bf
gmtOffSetMilliseconds§-18000000
targetHighPrice§21.0
targetLowPrice§4.0
targetMeanPrice§11.86
targetMedianPrice§10.0
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§7
quickRatio§8.268
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
